Biovail Labs Intl Company Profile
✉ Email this page to a colleague
What is the competitive landscape for BIOVAIL LABS INTL, and what generic and branded alternatives to BIOVAIL LABS INTL drugs are available?
BIOVAIL LABS INTL has four approved drugs.
Drugs and US Patents for Biovail Labs Intl
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Biovail Labs Intl | CITALOPRAM HYDROBROMIDE | citalopram hydrobromide | TABLET, ORALLY DISINTEGRATING;ORAL | 021763-001 | Dec 20, 2005 | DISCN | Yes | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Biovail Labs Intl | CITALOPRAM HYDROBROMIDE | citalopram hydrobromide | TABLET, ORALLY DISINTEGRATING;ORAL | 021763-002 | Dec 20, 2005 | DISCN | Yes | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Biovail Labs Intl | CARDIZEM | diltiazem hydrochloride | INJECTABLE;INJECTION | 020027-001 | Oct 24, 1991 | DISCN | Yes | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Biovail Labs Intl | TOVALT ODT | zolpidem tartrate | TABLET, ORALLY DISINTEGRATING;ORAL | 021412-001 | Apr 25, 2007 | DISCN | Yes | No | ⤷ Subscribe | ⤷ Subscribe | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Biovail Labs Intl
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Biovail Labs Intl | VASOTEC | enalaprilat | INJECTABLE;INJECTION | 019309-001 | Feb 9, 1988 | 4,374,829*PED | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.